Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Monique Spillman

Concepts (262)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2023
458
1.800
 Why?
Endometrial Neoplasms
5
2015
143
0.820
 Why?
Gynecology
5
2020
52
0.780
 Why?
Genital Neoplasms, Female
2
2020
48
0.730
 Why?
Gene Expression Regulation, Neoplastic
10
2019
853
0.720
 Why?
Cystadenocarcinoma, Serous
4
2021
73
0.680
 Why?
Infection Control
1
2020
46
0.650
 Why?
Ethics, Medical
1
2020
44
0.640
 Why?
Communication
1
2020
254
0.570
 Why?
Conflict of Interest
3
2016
24
0.560
 Why?
Medical Oncology
3
2020
96
0.550
 Why?
Uterus
1
2018
88
0.550
 Why?
Robotics
2
2014
43
0.530
 Why?
Pneumonia, Viral
1
2020
177
0.530
 Why?
Coronavirus Infections
1
2020
188
0.520
 Why?
Peptides
3
2015
234
0.520
 Why?
Receptors, Estrogen
5
2017
131
0.520
 Why?
Medroxyprogesterone Acetate
1
2015
6
0.490
 Why?
Fallopian Tube Neoplasms
2
2013
15
0.490
 Why?
Pandemics
1
2020
579
0.470
 Why?
Antineoplastic Agents, Hormonal
1
2015
53
0.470
 Why?
Glycoproteins
1
2015
122
0.460
 Why?
Gynecologic Surgical Procedures
2
2014
29
0.460
 Why?
Neoplastic Stem Cells
1
2015
90
0.460
 Why?
Adenocarcinoma
2
2015
401
0.440
 Why?
Antigens, CD
1
2015
215
0.440
 Why?
Female
34
2023
28055
0.400
 Why?
Salpingectomy
1
2013
6
0.400
 Why?
General Surgery
1
2014
105
0.400
 Why?
Pelvic Neoplasms
1
2013
13
0.400
 Why?
MicroRNAs
4
2021
385
0.400
 Why?
Peritoneal Neoplasms
2
2011
65
0.390
 Why?
Estrogens
2
2012
223
0.390
 Why?
Clinical Trials as Topic
2
2007
463
0.370
 Why?
Medicare Part B
1
2011
5
0.360
 Why?
Professional Corporations
1
2011
1
0.360
 Why?
Marketing of Health Services
1
2011
7
0.360
 Why?
Physicians
2
2016
235
0.360
 Why?
Reimbursement Mechanisms
1
2011
24
0.360
 Why?
Cell Line, Tumor
11
2016
1418
0.360
 Why?
Social Responsibility
1
2011
25
0.360
 Why?
Receptors, Progesterone
4
2015
66
0.350
 Why?
Trust
1
2011
60
0.350
 Why?
Humans
42
2023
52114
0.340
 Why?
Carcinoma, Large Cell
1
2010
16
0.340
 Why?
Carcinoma, Neuroendocrine
1
2010
25
0.340
 Why?
Health Care Reform
1
2010
22
0.330
 Why?
Interprofessional Relations
1
2011
90
0.330
 Why?
Physician-Patient Relations
1
2011
143
0.320
 Why?
Breast Neoplasms
4
2012
1199
0.320
 Why?
Uterine Neoplasms
2
2019
59
0.290
 Why?
Transplantation, Heterologous
2
2012
78
0.280
 Why?
Uterine Cervical Neoplasms
1
2010
299
0.270
 Why?
Physician's Role
2
2011
50
0.270
 Why?
MAP Kinase Kinase 4
1
2007
30
0.260
 Why?
Apoptosis
5
2016
1117
0.260
 Why?
Advance Directives
1
2007
26
0.260
 Why?
Genes, Tumor Suppressor
1
2007
73
0.260
 Why?
Patient Dropouts
1
2007
51
0.260
 Why?
Gene Expression Regulation, Enzymologic
1
2007
181
0.240
 Why?
Claudin-4
2
2016
7
0.230
 Why?
Receptors, Transforming Growth Factor beta
1
2005
29
0.230
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1020
0.220
 Why?
Ovary
1
2004
103
0.220
 Why?
Hysterectomy
2
2014
90
0.220
 Why?
Epithelial Cells
1
2004
214
0.200
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2017
580
0.200
 Why?
Aged
11
2021
10142
0.190
 Why?
Neoplasm Staging
4
2021
766
0.190
 Why?
Middle Aged
12
2021
13028
0.190
 Why?
Gene Expression Profiling
3
2019
1101
0.180
 Why?
Cisplatin
2
2015
284
0.180
 Why?
Immunohistochemistry
6
2017
975
0.170
 Why?
Cell Movement
3
2016
273
0.170
 Why?
Resource Allocation
1
2020
14
0.170
 Why?
Standard of Care
1
2020
17
0.170
 Why?
Disclosure
2
2016
40
0.160
 Why?
Loss of Heterozygosity
2
2013
78
0.160
 Why?
Lymphatic Metastasis
2
2010
210
0.160
 Why?
Leiomyoma
1
2019
22
0.150
 Why?
Leiomyosarcoma
1
2019
22
0.150
 Why?
Early Detection of Cancer
1
2021
183
0.150
 Why?
Neoplasm Invasiveness
3
2015
277
0.150
 Why?
Xenograft Model Antitumor Assays
4
2012
216
0.150
 Why?
Informed Consent
3
2004
95
0.150
 Why?
RNA-Binding Proteins
2
2019
134
0.150
 Why?
Critical Care
1
2020
214
0.140
 Why?
Death
1
2018
23
0.140
 Why?
Living Donors
1
2018
27
0.140
 Why?
Neoplasms, Glandular and Epithelial
2
2015
42
0.140
 Why?
Palliative Care
1
2020
195
0.140
 Why?
Carcinosarcoma
1
2017
18
0.140
 Why?
Microfilament Proteins
1
2017
44
0.140
 Why?
Sequence Analysis, RNA
1
2017
96
0.130
 Why?
United States
4
2016
5168
0.130
 Why?
Mice, Nude
3
2012
231
0.130
 Why?
Adult
7
2021
14095
0.130
 Why?
Industry
1
2016
16
0.120
 Why?
Keratin-5
1
2015
2
0.120
 Why?
Carrier Proteins
1
2017
316
0.120
 Why?
Cell Count
1
2015
143
0.120
 Why?
Receptors, Androgen
1
2015
47
0.120
 Why?
Cell Proliferation
4
2015
1017
0.120
 Why?
Prognosis
4
2017
2093
0.120
 Why?
Neoplasm Seeding
1
2014
4
0.110
 Why?
Genetic Privacy
2
2004
3
0.110
 Why?
Alanine
1
2014
43
0.110
 Why?
Triazines
1
2014
25
0.110
 Why?
Endometrium
1
2014
43
0.110
 Why?
Genes, BRCA2
1
2013
13
0.100
 Why?
Mice
6
2016
5877
0.100
 Why?
Genes, BRCA1
1
2013
19
0.100
 Why?
Insurance, Health, Reimbursement
1
2013
24
0.100
 Why?
Health Care Costs
2
2013
174
0.100
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
7
0.100
 Why?
DNA Methylation
3
2023
583
0.100
 Why?
Risk Reduction Behavior
1
2013
58
0.100
 Why?
Carcinoma, Lobular
1
2012
32
0.100
 Why?
DNA-Binding Proteins
2
2013
424
0.100
 Why?
Lymph Nodes
1
2014
252
0.090
 Why?
Paclitaxel
1
2012
90
0.090
 Why?
Antibodies, Neoplasm
1
2012
27
0.090
 Why?
Judicial Role
1
2011
6
0.090
 Why?
Coercion
1
2011
9
0.090
 Why?
Medicare Payment Advisory Commission
1
2011
2
0.090
 Why?
Personal Autonomy
1
2011
16
0.090
 Why?
Women
1
2011
30
0.090
 Why?
Prejudice
1
2011
37
0.090
 Why?
Homeodomain Proteins
1
2012
80
0.090
 Why?
Quality of Health Care
1
2013
187
0.090
 Why?
Politics
1
2011
28
0.090
 Why?
Violence
1
2011
61
0.090
 Why?
M Phase Cell Cycle Checkpoints
1
2011
5
0.090
 Why?
Taxoids
1
2011
38
0.090
 Why?
Selective Estrogen Receptor Modulators
1
2010
23
0.080
 Why?
RNA, Messenger
2
2012
1135
0.080
 Why?
Organ Specificity
1
2010
116
0.080
 Why?
Immunoenzyme Techniques
1
2010
135
0.080
 Why?
Obstetrics
1
2011
89
0.080
 Why?
Models, Statistical
1
2011
231
0.080
 Why?
Neoplasm Recurrence, Local
1
2014
630
0.080
 Why?
Cesarean Section
1
2011
183
0.080
 Why?
Alcohol Drinking
1
2011
236
0.080
 Why?
Blotting, Western
1
2010
588
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
411
0.080
 Why?
Societies, Medical
1
2010
200
0.080
 Why?
Transfection
2
2012
366
0.080
 Why?
Phosphorylation
2
2008
523
0.070
 Why?
Animals
6
2016
13332
0.070
 Why?
Aging
1
2013
701
0.070
 Why?
Aged, 80 and over
4
2021
3382
0.070
 Why?
Alleles
2
2006
277
0.070
 Why?
Antineoplastic Agents
1
2015
1214
0.070
 Why?
Case-Control Studies
2
2014
1193
0.070
 Why?
Chimera
1
2007
10
0.070
 Why?
CpG Islands
1
2007
114
0.060
 Why?
MAP Kinase Signaling System
1
2007
126
0.060
 Why?
Genomic Imprinting
1
2006
12
0.060
 Why?
Insulin-Like Growth Factor II
1
2006
18
0.060
 Why?
RNA, Untranslated
1
2006
15
0.060
 Why?
Health Services Accessibility
1
2010
438
0.060
 Why?
Base Sequence
1
2007
627
0.060
 Why?
Molecular Sequence Data
1
2007
766
0.060
 Why?
Repetitive Sequences, Amino Acid
1
2005
1
0.060
 Why?
Models, Biological
2
2008
731
0.060
 Why?
North Carolina
1
2005
55
0.060
 Why?
Carcinoma
1
2006
136
0.060
 Why?
Databases, Nucleic Acid
1
2004
10
0.060
 Why?
Telomerase
1
2004
26
0.060
 Why?
Promoter Regions, Genetic
1
2007
465
0.060
 Why?
Tumor Burden
2
2016
133
0.050
 Why?
Polymorphism, Genetic
1
2005
182
0.050
 Why?
RNA, Small Interfering
2
2016
215
0.050
 Why?
RNA Interference
2
2016
185
0.050
 Why?
Cell Survival
2
2016
596
0.050
 Why?
Family Health
1
2004
78
0.050
 Why?
Genetic Counseling
1
2004
44
0.050
 Why?
Genomics
1
2004
265
0.050
 Why?
Epigenesis, Genetic
1
2006
401
0.050
 Why?
Researcher-Subject Relations
1
2002
1
0.050
 Why?
Ethical Review
1
2002
2
0.050
 Why?
Contract Services
1
2002
13
0.050
 Why?
Financial Support
1
2002
3
0.050
 Why?
Genetic Predisposition to Disease
1
2005
528
0.050
 Why?
Mice, SCID
2
2012
178
0.050
 Why?
Cell Line
1
2004
1018
0.050
 Why?
Health Care Sector
1
2002
15
0.050
 Why?
Biotechnology
1
2002
15
0.050
 Why?
Drug Industry
1
2002
39
0.050
 Why?
Research Support as Topic
1
2002
44
0.040
 Why?
Research Subjects
1
2002
53
0.040
 Why?
Neoplasm Grading
1
2021
125
0.040
 Why?
Patient Selection
1
2002
265
0.040
 Why?
Cooperative Behavior
1
2002
226
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
11
0.040
 Why?
Cytoskeletal Proteins
1
2019
47
0.040
 Why?
Microtubule-Associated Proteins
1
2019
61
0.040
 Why?
Risk Assessment
1
2023
1339
0.040
 Why?
Biomedical Research
1
2002
262
0.040
 Why?
Cell Cycle Proteins
1
2019
167
0.040
 Why?
Sensitivity and Specificity
1
2019
871
0.030
 Why?
Cohort Studies
1
2021
1541
0.030
 Why?
Caspase 3
1
2016
91
0.030
 Why?
Retrospective Studies
2
2021
6610
0.030
 Why?
Diagnosis, Differential
1
2019
1031
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Prospective Studies
1
2021
2424
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2015
57
0.030
 Why?
HEK293 Cells
1
2015
231
0.030
 Why?
Exosomes
1
2015
56
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2014
10
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
184
0.030
 Why?
Peritoneal Cavity
1
2014
8
0.030
 Why?
Risk Factors
2
2014
3922
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2014
187
0.030
 Why?
Disease-Free Survival
1
2014
462
0.030
 Why?
Drug Resistance, Neoplasm
1
2015
324
0.030
 Why?
MCF-7 Cells
1
2013
62
0.020
 Why?
Germ-Line Mutation
1
2013
66
0.020
 Why?
Homologous Recombination
1
2013
41
0.020
 Why?
Amino Acid Substitution
1
2013
79
0.020
 Why?
Karyotyping
1
2012
78
0.020
 Why?
Extracellular Matrix Proteins
1
2013
69
0.020
 Why?
Anoikis
1
2012
9
0.020
 Why?
Transduction, Genetic
1
2012
44
0.020
 Why?
Tubulin
1
2012
22
0.020
 Why?
Databases, Factual
1
2016
714
0.020
 Why?
Mice, Inbred NOD
1
2012
90
0.020
 Why?
Tamoxifen
1
2012
59
0.020
 Why?
Signal Transduction
2
2011
1699
0.020
 Why?
DNA Fingerprinting
1
2012
61
0.020
 Why?
Cell Adhesion
1
2012
163
0.020
 Why?
Antibody Specificity
1
2012
36
0.020
 Why?
Amino Acid Sequence
1
2013
566
0.020
 Why?
Perioperative Period
1
2011
21
0.020
 Why?
Tumor Suppressor Protein p53
1
2013
224
0.020
 Why?
Estradiol
1
2012
217
0.020
 Why?
Disease Models, Animal
1
2016
1467
0.020
 Why?
Microtubules
1
2011
34
0.020
 Why?
Cell Cycle Checkpoints
1
2011
32
0.020
 Why?
Gene Expression
1
2013
618
0.020
 Why?
Mitosis
1
2011
87
0.020
 Why?
Regression Analysis
1
2011
399
0.020
 Why?
HeLa Cells
1
2011
242
0.020
 Why?
Disease Progression
1
2012
866
0.020
 Why?
Cells, Cultured
1
2013
1568
0.020
 Why?
Severity of Illness Index
1
2011
1035
0.020
 Why?
Progesterone Congeners
1
2008
5
0.020
 Why?
Progesterone
1
2008
58
0.020
 Why?
Mutation
1
2013
1318
0.020
 Why?
Protein Kinases
1
2008
72
0.020
 Why?
Tumor Cells, Cultured
1
2008
445
0.020
 Why?
Cell Nucleus
1
2008
188
0.020
 Why?
Transcriptional Activation
1
2006
128
0.010
 Why?
DNA, Neoplasm
1
2006
146
0.010
 Why?
Protein Structure, Tertiary
1
2006
252
0.010
 Why?
Binding Sites
1
2006
375
0.010
 Why?
Repressor Proteins
1
2006
150
0.010
 Why?
Pregnancy
1
2011
2658
0.010
 Why?
Truth Disclosure
1
2004
16
0.010
 Why?
Genetic Diseases, Inborn
1
2004
24
0.010
 Why?
Male
1
2011
26652
0.010
 Why?
Spillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (262) concept(s)
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department